AIM IMMUNOTECH INC. Sale Leaseback Transaction, Deferred Gain, Gross
AIM IMMUNOTECH INC. (AIM) had Sale Leaseback Transaction, Deferred Gain, Gross of $185.00 thousand as of 2021-03-31, per its 10-Q filed 2021-05-17.
Discontinued › Notes › Leases
us-gaap:SaleLeasebackTransactionDeferredGainGross · last filed 2021-05-17
- 2021-03-31: Sale Leaseback Transaction, Deferred Gain, Gross $185.00K.
- 2020-12-31: Sale Leaseback Transaction, Deferred Gain, Gross $192.00K.
- 2020-09-30: Sale Leaseback Transaction, Deferred Gain, Gross $199.00K.
- 2020-06-30: Sale Leaseback Transaction, Deferred Gain, Gross $205.00K.
| Period end | Sale Leaseback Transaction, Deferred Gain, Gross |
|---|---|
| 2021-03-31 | $185.00K 10-Q · filed 2021-05-17 |
| 2020-12-31 | $192.00K 10-K · filed 2021-03-31 |
| 2020-09-30 | $199.00K 10-Q · filed 2020-11-12 |
| 2020-06-30 | $205.00K 10-Q · filed 2020-08-14 |
| 2020-03-31 | $212.00K 10-Q · filed 2020-05-14 |
| 2019-12-31 | $219.00K 10-K · filed 2020-03-30 |
| 2019-09-30 | $225.00K 10-Q · filed 2019-11-14 |
| 2019-06-30 | $232.00K 10-Q · filed 2019-08-14 |
| 2019-03-31 | $239.00K 10-Q · filed 2019-05-15 |
| 2018-12-31 | $245.00K 10-K · filed 2019-04-01 |
| 2018-09-30 | $252.00K 10-Q · filed 2018-11-14 |
| 2018-06-30 | $259.00K 10-Q · filed 2018-08-14 |
| 2018-03-31 | $265.00K 10-Q · filed 2018-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |